Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial

已完结 10 由达姆发布于 2026/9/8 15:39:17

DOI:10.1016/s0140-6736(25)02155-5
作者：Liana K Billings, Stanley Hsia, Harold Bays, Beth Tidemann-Miller, Jessica O’Hagan, Lai San Tham, Annabelle Butler, Christof Kazda, Kieren J Mather, Tamer Coskun
文献类型：期刊论文
补充材料：只需要正文

Elsevier

应助信息

1天前

Koko

5a997076ab5a11f1985c34735aa3bc31.pdf 已采纳

1天前

caomin

6f861386ab5811f18cfa208810ba6e4f.pdf 已驳回

1天前

Book学术机器人

2026/9/8 15:39:18 未找到该文献，机器人已退出，请等待人工下载

2026/9/8 15:39:17 Book学术AI机器人收到请求，开始寻找文献

2026/9/8 15:39:17 已向机器人发送请求

1天前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SpringerThe Impact of the Internet upon Chinese Nursing Students: A Neuman Model Perspective Focusing on the Integration of Spiritual Care.